Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
ACS Medicinal Chemistry Letters
|
July 28, 2012
Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS
Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Biochimica Et Biophysica Acta
|
May 2, 2006
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Karen M Smith, Samantha Matson, Wayne R Matson, et al.
The Journal of Biological Chemistry
|
February 3, 2007
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide
Nadia Moretto, Angelo Bolchi, Claudio Rivetti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 3, 2006
Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response
Junghee Lee, Bela Kosaras, Hossein Aleyasin, et al.
The European Journal of Neuroscience
|
August 10, 2007
Nortriptyline delays disease onset in models of chronic neurodegeneration
Hongyan Wang, Yingjun Guan, Xin Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 2003
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway
Hoon Ryu, Junghee Lee, Beatrix A Olofsson, et al.
Nature Neuroscience
|
May 20, 2014
Inhibition of mitochondrial protein import by mutant huntingtin
Hiroko Yano, Sergei V Baranov, Oxana V Baranova, et al.
Human Molecular Genetics
|
May 25, 2010
In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects
Mathilde Faideau, Jinho Kim, Kerry Cormier, et al.
The Journal of Clinical Investigation
|
October 12, 2011
Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease
Guy Keryer, Jose R Pineda, Géraldine Liot, et al.
Journal of Neurochemistry
|
September 28, 2004
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation
Jonathan H Fox, David S Barber, Bhupinder Singh, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
ACS Medicinal Chemistry Letters
|
July 28, 2012
Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS
Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Biochimica Et Biophysica Acta
|
May 2, 2006
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Karen M Smith, Samantha Matson, Wayne R Matson, et al.
The Journal of Biological Chemistry
|
February 3, 2007
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide
Nadia Moretto, Angelo Bolchi, Claudio Rivetti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 3, 2006
Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response
Junghee Lee, Bela Kosaras, Hossein Aleyasin, et al.
The European Journal of Neuroscience
|
August 10, 2007
Nortriptyline delays disease onset in models of chronic neurodegeneration
Hongyan Wang, Yingjun Guan, Xin Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 2003
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway
Hoon Ryu, Junghee Lee, Beatrix A Olofsson, et al.
Nature Neuroscience
|
May 20, 2014
Inhibition of mitochondrial protein import by mutant huntingtin
Hiroko Yano, Sergei V Baranov, Oxana V Baranova, et al.
Human Molecular Genetics
|
May 25, 2010
In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects
Mathilde Faideau, Jinho Kim, Kerry Cormier, et al.
The Journal of Clinical Investigation
|
October 12, 2011
Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease
Guy Keryer, Jose R Pineda, Géraldine Liot, et al.
Journal of Neurochemistry
|
September 28, 2004
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation
Jonathan H Fox, David S Barber, Bhupinder Singh, et al.
Page
of 9